SAI - Detailed view

Information for prof.

Leaflet

Report error

GAVRETO Kaps 100 mg Ds 120 Stk

Drug

Gavreto, Hartkapseln
Nichtkleinzelliges Lungenkarzinom mit Rearrangement des RET (Rearranged during Transfection)-Gens; RET-Fusion-positives Schilddrüsenkarzinom
L01EX - OTHER PROTEIN KINASE INHIBITORS
07.16.1. – cytostatics

HAM – Human medicine
KAHA – Capsule, hard
S – synthetic products for human use
A – Dispensed once only on prescription by a physician or veterinarian (A)

B – limited
68182
8/12/2021
9/27/2025

Dosage strength

Gavreto 100 mg, Hartkapseln
Nichtkleinzelliges Lungenkarzinom mit Rearrangement des RET (Rearranged during Transfection)-Gens; RET-Fusion-positives Schilddrüsenkarzinom
01
B – limited

Package

7680681820017
Out of trade from / since 8/12/2023
A/R – Authorised / referenced 

120 capsule(s)

001
B – limited

Declaration

Component

100 mg pralsetinibum
hypromellosum
cellulosum microcristallinum
natrii hydrogenocarbonas
22.3 mg natrium
acidum citricum
magnesii stearas
amylum pregelificatum
hypromellosum
E 171
E 133
lacca
propylenglycolum
ammonii hydroxidum
kalii hydroxidum
E 171

Spezialitätenliste***

This package has been removed from the list of specialties. The displayed data correspond to the latest status.
SL
-
-
6432.35
None
Yes
10%
No

Authorisation holder

7601001010208
Blueprint Medicines (Switzerland)
Baarerstrasse 8
6300 Zug (ZG)

Date of revision of the text

12/1/2024

Information for prof.

Leaflet

Report error

Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.